Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-inferiority Study of Bi-Profenid® 200 mg Versus Bi-Profenid® 300 mg in Patients Presenting With Pain Related to Closed, Benign, Acute Post-traumatic Conditions of the Motor System or Acute, Non-infectious Rheumatologic Conditions

NCT00810121 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00810121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00810121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-inferiority Study of Bi-Profenid® 200 mg Versus Bi-Profenid® 300 mg in Patients Presenting With Pain Related to Closed, Benign, Acute Post-traumatic Conditions of the Motor System or Acute, Non-infectious Rheumatologic Conditions
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2008
Completion date
June 30, 2009
Enrollment
409 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain